×
497
Fashion Jobs
JOSEPH LTD
Full Time Menswear Supervisor (Mayfair)
Permanent · LONDON
MICHAEL KORS
Account Executive
Permanent · LONDON
OUTSIDE THE BOX RECRUITMENT
Flagship General Manager – Luxury Fashion – Regent st – £80k-£90k + Bonus
Permanent · LONDON
FOUR SEASONS RECRUITMENT
Online Customer Service Manager
Permanent · HUNGERFORD
TOO FACED
Business Manager - Boots, Brent Cross
Permanent · LONDON
FOUR SEASONS RECRUITMENT
Merchandising Manager
Permanent · LONDON
BIMBA Y LOLA
Part Time Sales Assistant Kings Road
Permanent · LONDON
BIMBA Y LOLA
Sales Assistant Richmond
Permanent · LONDON
BIMBA Y LOLA
Part Time Sales Assistant Notting Hill
Permanent · LONDON
TOO FACED
Business Manager - Boots Chelmsford
Permanent · LONDON
FOUR SEASONS RECRUITMENT
Showroom Sales Representative
Permanent · LONDON
TOO FACED
Business Manager - Debenhams, Oxford Street
Permanent · LONDON
TOO FACED
Business Manager - John Lewis Brent Cross
Permanent · LONDON
OUTSIDE THE BOX RECRUITMENT
Ltrtw & Mtm Client Service Manager – Luxury Ladieswear – Knightsbridge – £30k-£40k + Comm
Permanent · LONDON
OUTSIDE THE BOX RECRUITMENT
Haute Couture Client Service Manager – Luxury Ladieswear – Mayfair– £40k-£60k + Comm
Permanent · LONDON
MAJE
Sales Supervisor, Full-Time - Harrods, London
Permanent · LONDON
BIMBA Y LOLA
Part Time Sales Assistant Canary Wharf
Permanent · LONDON
HEAD OFFICE
Brand Manager
Permanent · LONDON
BETTY BARCLAY GROUP GMBH & CO KG
Retail Operations Manager
Permanent · LONDON
RETAIL PERM
Beauty Salon Manager
Permanent · LONDON
TOO FACED
Business Manager - Liverpool - New Mersey Retail pk (Speke), UK
Permanent ·
TOO FACED
Business Manager - Lisburn Sprucefield sc, UK
Permanent ·

J&J forecasts disappointing 2019 sales, defends talc safety

By
Reuters
Published
today Jan 22, 2019
Reading time
access_time 2 minutes
Share
Download
Download the article
Print
Click here to print
Text size
aA+ aA-

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates as the healthcare conglomerate faces increasing competition for some of its older drugs.


Reuters on Dec. 14 published a special report detailing that the company knew for decades that cancer-causing asbestos could be found in the company's Baby Powder - Reuters


J&J said it expects full-year sales of $80.4 billion to $81.2 billion, below Wall Street estimates of $82.69 billion, according to IBES data from Refinitiv.

Strength in the pharmaceuticals business helped offset higher costs, including a doubling of litigation expense in the fourth quarter to $1.29 billion.

Most of that was related to resolving older lawsuits in its medical devices business, spokesman Ernie Knewitz said in an email response to Reuters. For the full year, litigation expenses rose to $1.9 billion from $1.3 billion in 2017. About 10 percent of that total was related to talc, Knewitz said.

J&J is facing more than 11,000 lawsuits over the safety of talc in its products, including baby powder, alleging that its use caused cancer.

“We remain committed to ensuring the facts about our talc are understood and we will continue to defend the safety of our products,” Gorsky said.

Reuters on Dec. 14 published a special report detailing that the company knew for decades that cancer-causing asbestos could be found in its talc.

J&J has repeatedly said that its talc products are safe, and that decades of studies have shown them to be asbestos-free and that they do not cause cancer.

Sales in the quarter rose about 1 percent to $20.39 billion, topping Wall Street estimates of $20.20 billion.
 

© Thomson Reuters 2019 All rights reserved.